ACB
Price
$5.65
Change
-$0.03 (-0.53%)
Updated
Oct 3, 04:59 PM (EDT)
Capitalization
320.35M
34 days until earnings call
COSM
Price
$1.06
Change
-$0.05 (-4.50%)
Updated
Oct 3, 04:59 PM (EDT)
Capitalization
34.43M
Interact to see
Advertisement

ACB vs COSM

Header iconACB vs COSM Comparison
Open Charts ACB vs COSMBanner chart's image
Aurora Cannabis
Price$5.65
Change-$0.03 (-0.53%)
Volume$8.56K
Capitalization320.35M
Cosmos Health
Price$1.06
Change-$0.05 (-4.50%)
Volume$18.04K
Capitalization34.43M
ACB vs COSM Comparison Chart in %
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. COSM commentary
Oct 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and COSM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 04, 2025
Stock price -- (ACB: $5.68 vs. COSM: $1.11)
Brand notoriety: ACB: Notable vs. COSM: Not notable
ACB represents the Pharmaceuticals: Generic, while COSM is part of the Medical Distributors industry
Current volume relative to the 65-day Moving Average: ACB: 90% vs. COSM: 131%
Market capitalization -- ACB: $320.35M vs. COSM: $34.43M
ACB [@Pharmaceuticals: Generic] is valued at $320.35M. COSM’s [@Medical Distributors] market capitalization is $34.43M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.92B to $0. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.37B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.97B. The average market capitalization across the [@Medical Distributors] industry is $10.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileCOSM’s FA Score has 1 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • COSM’s FA Score: 1 green, 4 red.
According to our system of comparison, COSM is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 6 TA indicator(s) are bullish while COSM’s TA Score has 5 bullish TA indicator(s).

  • ACB’s TA Score: 6 bullish, 4 bearish.
  • COSM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ACB is a better buy in the short-term than COSM.

Price Growth

ACB (@Pharmaceuticals: Generic) experienced а +14.75% price change this week, while COSM (@Medical Distributors) price change was +1.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.83%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was +55.25%.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.84%. For the same industry, the average monthly price growth was +0.34%, and the average quarterly price growth was +9.11%.

Reported Earning Dates

ACB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.83% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Medical Distributors (-0.84% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($320M) has a higher market cap than COSM($34.4M). COSM YTD gains are higher at: 65.919 vs. ACB (33.647). ACB has higher annual earnings (EBITDA): 26.6M vs. COSM (-12.84M). ACB has more cash in the bank: 140M vs. COSM (686K). COSM has less debt than ACB: COSM (15.6M) vs ACB (102M). ACB has higher revenues than COSM: ACB (358M) vs COSM (55.1M).
ACBCOSMACB / COSM
Capitalization320M34.4M930%
EBITDA26.6M-12.84M-207%
Gain YTD33.64765.91951%
P/E Ratio19.44N/A-
Revenue358M55.1M650%
Total Cash140M686K20,408%
Total Debt102M15.6M654%
FUNDAMENTALS RATINGS
ACB vs COSM: Fundamental Ratings
ACB
COSM
OUTLOOK RATING
1..100
7326
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
4435
P/E GROWTH RATING
1..100
916
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (59) in the Pharmaceuticals Other industry is in the same range as COSM (78) in the null industry. This means that ACB’s stock grew similarly to COSM’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as COSM (100) in the null industry. This means that ACB’s stock grew similarly to COSM’s over the last 12 months.

ACB's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as COSM (98) in the null industry. This means that ACB’s stock grew similarly to COSM’s over the last 12 months.

COSM's Price Growth Rating (35) in the null industry is in the same range as ACB (44) in the Pharmaceuticals Other industry. This means that COSM’s stock grew similarly to ACB’s over the last 12 months.

COSM's P/E Growth Rating (6) in the null industry is significantly better than the same rating for ACB (91) in the Pharmaceuticals Other industry. This means that COSM’s stock grew significantly faster than ACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBCOSM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
79%
Bullish Trend 12 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CATX3.490.06
+1.75%
Perspective Therapeutics
HGTY12.130.18
+1.51%
Hagerty
ALK48.980.48
+0.99%
Alaska Air Group
BGFV1.44N/A
N/A
Big 5 Sporting Goods Corp
DELL147.37-2.31
-1.54%
Dell Technologies

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with SNDL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-0.87%
SNDL - ACB
65%
Loosely correlated
-0.39%
OGI - ACB
65%
Loosely correlated
-2.09%
CGC - ACB
64%
Loosely correlated
-1.45%
CRON - ACB
58%
Loosely correlated
-2.63%
TLRY - ACB
54%
Loosely correlated
-2.72%
More

COSM and

Correlation & Price change

A.I.dvisor tells us that COSM and YI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COSM and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COSM
1D Price
Change %
COSM100%
+0.91%
YI - COSM
21%
Poorly correlated
+0.11%
SUPN - COSM
20%
Poorly correlated
-0.17%
OGI - COSM
16%
Poorly correlated
-2.09%
INCR - COSM
14%
Poorly correlated
-2.42%
ACB - COSM
13%
Poorly correlated
-0.87%
More